March 05, 2020
Earlier this year, the CEO of Illumina gave a presentation in which he reaffirmed his company's intention to drive the cost of human genome sequencing down to a mere hundred dollars. This has ramifications for every branch of medicine, including rejuvenation biotechnology. Drastically declining costs In 2001, the year when the Human Genome Project was...
February 25, 2020
Recently, researcher Dr. Alexey Moskalev has published a mini review that takes a look at aging biomarkers and how some of them compare with each other [1]. A major challenge in developing therapies that target the aging processes in order to prevent or reverse age-related diseases is having accurate ways to determine if a therapeutic...
December 18, 2019
A new blood test could reveal your age, according to a new study published in Nature Medicine by researchers at the Wyss-Coray Lab at the Stanford School of Medicine [1]. Your real age is written in your blood The study saw researchers examining blood samples and the levels of various proteins within them in order...
November 29, 2019
A team of researchers, including Drs. Vadim Gladyshev and Steve Horvath, recently published a review of DNA methylation aging clocks, which use biomarkers to determine the biological age of a person. Aging causes epigenetic alterations to occur, including changes to DNA methylation, histone modification, transcriptional alterations (variance in gene expression), and remodeling of chromatin (a...
October 14, 2019
We're continuing to release talks from Ending Age-Related Diseases 2019, our highly successful two-day conference that featured talks from leading researchers and investors, bringing them together to discuss the future of aging and rejuvenation biotechnology. Dr. Qingsong Zhu, the COO of Insilico Medicine, discussed the use of deep learning in creating biomarkers for aging. Initially...
October 04, 2019
At the Ending Age-Related Diseases 2019 Conference in New York City, we had the opportunity to interview Dr. Justin Rebo from the drug discovery biotech company BioAge. BioAge is developing a drug discovery platform that uses machine learning and artificial intelligence to discover targets that have the potential to promote healthy lifespan (healthspan) by slowing...
